Under the liquidity contract entrusted by Innate Pharma to Natixis Securities, the following assets appeared on the liquidity account as at June 30, 2010:
- 108,104 shares of Innate Pharma, and
- 51,728.95 euros in cash.
For information, the following assets appeared on the liquidity account at the latest report:
- 69,741 shares of Innate Pharma, and
- 121,955.05 euros in cash.
| PR in english | 32.72 KB |
| CP en français | 32.07 KB |